| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 SFXN4 ABCC4 SLC10A2 SLC12A9 TSPOAP1 TMEM94 NPC1L1 SLC2A14 ANO7 ITGAV ATP2A1 ATP2A3 TAP1 ANKH CLCC1 | 4.97e-06 | 1289 | 68 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 SFXN4 ABCC4 SLC10A2 SLC12A9 TSPOAP1 TMEM94 SLC2A14 ANO7 ITGAV ATP2A1 ATP2A3 TAP1 ANKH CLCC1 | 7.86e-06 | 1180 | 68 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 ABCC4 SLC10A2 SLC12A9 TSPOAP1 TMEM94 ANO7 ITGAV ATP2A1 ATP2A3 ANKH CLCC1 | 8.47e-06 | 758 | 68 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.55e-05 | 171 | 68 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 ABCC4 SLC10A2 SLC12A9 TMEM94 ATP2A1 ATP2A3 TAP1 ANKH | 3.32e-05 | 477 | 68 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 3.42e-05 | 3 | 68 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.50e-05 | 109 | 68 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 6.83e-05 | 4 | 68 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | adrenomedullin receptor activity | 6.83e-05 | 4 | 68 | 2 | GO:0001605 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 SFXN4 SLC10A2 SLC12A9 TSPOAP1 TMEM94 ANO7 ITGAV ATP2A1 ATP2A3 CLCC1 | 7.01e-05 | 793 | 68 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 9.05e-05 | 133 | 68 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | scavenger receptor binding | 1.14e-04 | 5 | 68 | 2 | GO:0005124 | |
| GeneOntologyMolecularFunction | N-formyl peptide receptor activity | 1.14e-04 | 5 | 68 | 2 | GO:0004982 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.15e-04 | 140 | 68 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.77e-04 | 465 | 68 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcitonin family receptor activity | 2.37e-04 | 7 | 68 | 2 | GO:0097642 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.49e-04 | 36 | 68 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.49e-04 | 36 | 68 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.52e-04 | 178 | 68 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 5.58e-04 | 301 | 68 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 6.16e-04 | 11 | 68 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 8.75e-04 | 125 | 68 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.01e-03 | 14 | 68 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.07e-03 | 59 | 68 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | RAGE receptor binding | 1.17e-03 | 15 | 68 | 2 | GO:0050786 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.24e-03 | 62 | 68 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.27e-03 | 627 | 68 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.76e-03 | 151 | 68 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.76e-03 | 151 | 68 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.83e-03 | 664 | 68 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.76e-03 | 23 | 68 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | virus receptor activity | 3.06e-03 | 85 | 68 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 3.16e-03 | 86 | 68 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | opsonin binding | 3.26e-03 | 25 | 68 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.52e-03 | 26 | 68 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.33e-03 | 194 | 68 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 4.37e-03 | 29 | 68 | 2 | GO:0015216 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.49e-03 | 196 | 68 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 5.64e-03 | 33 | 68 | 2 | GO:0015215 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.98e-03 | 34 | 68 | 2 | GO:0015125 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.81e-03 | 119 | 68 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 7.81e-03 | 39 | 68 | 2 | GO:0015605 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 3.41e-07 | 5 | 68 | 3 | GO:0046967 | |
| GeneOntologyCellularComponent | secretory granule membrane | 1.05e-04 | 329 | 69 | 7 | GO:0030667 | |
| GeneOntologyCellularComponent | integrin complex | 1.59e-04 | 32 | 69 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RAB5IF TMEM94 GPR37 SREBF1 PIGW CYP4F22 ATP2A1 ATP2A3 CYP4F11 TAP1 PIGO CLCC1 CDKAL1 | 2.74e-04 | 1293 | 69 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RAB5IF TMEM94 GPR37 SREBF1 PIGW CYP4F22 ATP2A1 ATP2A3 CYP4F11 TAP1 PIGO CLCC1 CDKAL1 | 2.87e-04 | 1299 | 69 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RAB5IF TMEM94 GPR37 SREBF1 PIGW CYP4F22 ATP2A1 ATP2A3 CYP4F11 TAP1 PIGO CLCC1 CDKAL1 | 3.53e-04 | 1327 | 69 | 13 | GO:0042175 |
| GeneOntologyCellularComponent | chromaffin granule membrane | 3.81e-04 | 9 | 69 | 2 | GO:0042584 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 3.81e-04 | 9 | 69 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | secretory granule | ABCC4 FPR1 FPR2 SLC2A14 SYT1 SYT2 IDH1 HUWE1 CALCRL ITGAV TREML1 | 4.56e-04 | 1014 | 69 | 11 | GO:0030141 |
| GeneOntologyCellularComponent | platelet dense tubular network | 5.79e-04 | 11 | 69 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | dense core granule | 8.42e-04 | 56 | 69 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | cell surface | NPTN CD1A ABCC4 GPR37 PVR ITGA8 CLEC7A ITGA5 SUCNR1 ITGAV TREML1 | 9.73e-04 | 1111 | 69 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 9.80e-04 | 59 | 69 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CD1A ABCC4 WASHC5 FPR1 FPR2 NPC1L1 SREBF1 SLC2A14 SYT1 SYT2 ITGAV TAP1 | 1.08e-03 | 1307 | 69 | 12 | GO:0030659 |
| GeneOntologyCellularComponent | chromaffin granule | 1.10e-03 | 15 | 69 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | vesicle membrane | CD1A ABCC4 WASHC5 FPR1 FPR2 NPC1L1 SREBF1 SLC2A14 SYT1 SYT2 ITGAV TAP1 | 1.22e-03 | 1325 | 69 | 12 | GO:0012506 |
| GeneOntologyCellularComponent | secretory vesicle | ABCC4 FPR1 FPR2 SLC2A14 SYT1 SYT2 IDH1 HUWE1 CALCRL ITGAV TREML1 | 2.43e-03 | 1246 | 69 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 3.28e-03 | 185 | 69 | 4 | GO:0101002 | |
| Domain | Integrin_alpha | 7.46e-06 | 11 | 68 | 3 | PF00357 | |
| Domain | Synaptotagmin1 | 1.31e-05 | 2 | 68 | 2 | IPR015428 | |
| Domain | Integrin_alpha_C_CS | 2.50e-05 | 16 | 68 | 3 | IPR018184 | |
| Domain | - | 2.50e-05 | 16 | 68 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.50e-05 | 16 | 68 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.03e-05 | 17 | 68 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.03e-05 | 17 | 68 | 3 | PF00689 | |
| Domain | Integrin_alpha-2 | 3.62e-05 | 18 | 68 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 3.62e-05 | 18 | 68 | 3 | PF08441 | |
| Domain | Integrin_alpha | 3.62e-05 | 18 | 68 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 3.62e-05 | 18 | 68 | 3 | PS00242 | |
| Domain | P-type_ATPase_IIA | 3.91e-05 | 3 | 68 | 2 | IPR005782 | |
| Domain | Int_alpha_beta-p | 4.29e-05 | 19 | 68 | 3 | IPR013519 | |
| Domain | Int_alpha | 4.29e-05 | 19 | 68 | 3 | SM00191 | |
| Domain | FG_GAP | 6.76e-05 | 22 | 68 | 3 | PS51470 | |
| Domain | rSAM_horseshoe | 7.80e-05 | 4 | 68 | 2 | IPR023404 | |
| Domain | - | 7.80e-05 | 4 | 68 | 2 | 3.80.30.20 | |
| Domain | FG-GAP | 8.84e-05 | 24 | 68 | 3 | PF01839 | |
| Domain | FG-GAP | 8.84e-05 | 24 | 68 | 3 | IPR013517 | |
| Domain | Integrin_dom | 1.00e-04 | 25 | 68 | 3 | IPR032695 | |
| Domain | Elp3 | 2.71e-04 | 7 | 68 | 2 | SM00729 | |
| Domain | Elp3/MiaB/NifB | 2.71e-04 | 7 | 68 | 2 | IPR006638 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.28e-04 | 37 | 68 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.28e-04 | 37 | 68 | 3 | PF00122 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.14e-04 | 40 | 68 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 4.14e-04 | 40 | 68 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.14e-04 | 40 | 68 | 3 | PS50227 | |
| Domain | rSAM | 4.63e-04 | 9 | 68 | 2 | IPR007197 | |
| Domain | Radical_SAM | 4.63e-04 | 9 | 68 | 2 | PF04055 | |
| Domain | Hydrolase_3 | 5.77e-04 | 10 | 68 | 2 | PF08282 | |
| Domain | Formyl_rcpt-rel | 5.77e-04 | 10 | 68 | 2 | IPR000826 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.00e-04 | 50 | 68 | 3 | PS00650 | |
| Domain | 7tm_2 | 8.00e-04 | 50 | 68 | 3 | PF00002 | |
| Domain | GPCR_2_secretin-like | 1.36e-03 | 60 | 68 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 1.36e-03 | 60 | 68 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.43e-03 | 61 | 68 | 3 | PS50261 | |
| Domain | Cation_ATPase_N | 1.92e-03 | 18 | 68 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 1.92e-03 | 18 | 68 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.15e-03 | 19 | 68 | 2 | IPR004014 | |
| Domain | Synaptotagmin | 2.38e-03 | 20 | 68 | 2 | IPR001565 | |
| Domain | ADAM_spacer1 | 3.15e-03 | 23 | 68 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.15e-03 | 23 | 68 | 2 | PF05986 | |
| Domain | ABC_membrane | 3.42e-03 | 24 | 68 | 2 | PF00664 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.42e-03 | 24 | 68 | 2 | IPR013273 | |
| Domain | HormR | 3.71e-03 | 25 | 68 | 2 | SM00008 | |
| Domain | ACR | 4.32e-03 | 27 | 68 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 4.32e-03 | 27 | 68 | 2 | IPR006586 | |
| Domain | ABC_TM1F | 4.64e-03 | 28 | 68 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 4.64e-03 | 28 | 68 | 2 | IPR011527 | |
| Domain | HRM | 4.64e-03 | 28 | 68 | 2 | PF02793 | |
| Domain | - | 6.04e-03 | 32 | 68 | 2 | 3.40.1110.10 | |
| Domain | - | 6.04e-03 | 32 | 68 | 2 | 2.70.150.10 | |
| Domain | GPS | 6.80e-03 | 34 | 68 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 6.80e-03 | 34 | 68 | 2 | IPR017983 | |
| Domain | GPS | 7.19e-03 | 35 | 68 | 2 | PF01825 | |
| Domain | ATPase_P-typ_cyto_domN | 7.19e-03 | 35 | 68 | 2 | IPR023299 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 2.08e-05 | 42 | 55 | 4 | M174 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 7.11e-05 | 21 | 55 | 3 | M27137 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 9.42e-05 | 23 | 55 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 9.42e-05 | 23 | 55 | 3 | M47720 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.22e-04 | 25 | 55 | 3 | MM14858 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.37e-04 | 26 | 55 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.37e-04 | 26 | 55 | 3 | M47719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.72e-04 | 28 | 55 | 3 | M47655 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.85e-04 | 73 | 55 | 4 | M39401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.12e-04 | 30 | 55 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.12e-04 | 30 | 55 | 3 | M47718 | |
| Pathway | WP_CYTOSINE_METHYLATION | 4.12e-04 | 8 | 55 | 2 | M39348 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 4.12e-04 | 8 | 55 | 2 | M27370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 4.12e-04 | 8 | 55 | 2 | M47955 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 4.12e-04 | 8 | 55 | 2 | MM15110 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.65e-04 | 39 | 55 | 3 | MM14601 | |
| Pathway | REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS | 6.59e-04 | 10 | 55 | 2 | M27018 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.65e-04 | 44 | 55 | 3 | M26969 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 9.12e-04 | 49 | 55 | 3 | M67 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 9.62e-04 | 12 | 55 | 2 | M27326 | |
| Pathway | REACTOME_EICOSANOIDS | 9.62e-04 | 12 | 55 | 2 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 9.62e-04 | 12 | 55 | 2 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 9.62e-04 | 12 | 55 | 2 | MM14845 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 9.62e-04 | 12 | 55 | 2 | M48096 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.32e-03 | 14 | 55 | 2 | MM15052 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.52e-03 | 15 | 55 | 2 | M27126 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.57e-03 | 59 | 55 | 3 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.72e-03 | 61 | 55 | 3 | MM14861 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.96e-03 | 17 | 55 | 2 | MM14907 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.96e-03 | 17 | 55 | 2 | M93 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.16e-03 | 66 | 55 | 3 | M18 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.20e-03 | 18 | 55 | 2 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 2.20e-03 | 18 | 55 | 2 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.20e-03 | 18 | 55 | 2 | MM14703 | |
| Pathway | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | 2.20e-03 | 18 | 55 | 2 | M1093 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 2.20e-03 | 18 | 55 | 2 | M27043 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.20e-03 | 18 | 55 | 2 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.20e-03 | 18 | 55 | 2 | MM14841 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.20e-03 | 18 | 55 | 2 | M614 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.45e-03 | 19 | 55 | 2 | MM15113 | |
| Pathway | WP_FOXA2_PATHWAY | 2.99e-03 | 21 | 55 | 2 | M42579 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.99e-03 | 21 | 55 | 2 | M878 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.00e-03 | 74 | 55 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.00e-03 | 74 | 55 | 3 | M16376 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.23e-03 | 76 | 55 | 3 | MM14867 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 3.55e-03 | 511 | 55 | 7 | MM15330 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.59e-03 | 23 | 55 | 2 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.59e-03 | 23 | 55 | 2 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.90e-03 | 24 | 55 | 2 | MM14834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS | 3.90e-03 | 24 | 55 | 2 | M47625 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.90e-03 | 24 | 55 | 2 | M630 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.14e-03 | 83 | 55 | 3 | M8728 | |
| Pathway | KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS | 4.23e-03 | 25 | 55 | 2 | M13265 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.28e-03 | 84 | 55 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.43e-03 | 85 | 55 | 3 | M16441 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.93e-03 | 27 | 55 | 2 | MM15053 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPTN ABCC4 NF1 CELSR3 PVR SREBF1 ITGA5 ITGAV ATP2A3 TAP1 PIGO CLCC1 CDKAL1 | 7.10e-07 | 1201 | 70 | 13 | 35696571 |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10477558 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35217703 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17692291 | ||
| Pubmed | Acute loss of TET function results in aggressive myeloid cancer in mice. | 3.99e-06 | 2 | 70 | 2 | 26607761 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 33920954 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2450560 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23147350 | ||
| Pubmed | Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. | 3.99e-06 | 2 | 70 | 2 | 27852070 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26071379 | ||
| Pubmed | Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. | 3.99e-06 | 2 | 70 | 2 | 14504267 | |
| Pubmed | TET proteins regulate Drosha expression and impact microRNAs in iNKT cells. | 3.99e-06 | 2 | 70 | 2 | 39364402 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24863484 | ||
| Pubmed | A Critical Role of Formyl Peptide Receptors in Host Defense against Escherichia coli. | 3.99e-06 | 2 | 70 | 2 | 32221037 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 38179947 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30540534 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2446925 | ||
| Pubmed | TET2 and TET3 loss disrupts small intestine differentiation and homeostasis. | 3.99e-06 | 2 | 70 | 2 | 37414790 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23686496 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27363302 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31120187 | ||
| Pubmed | Synaptotagmins 1 and 2 as mediators of rapid exocytosis at nerve terminals: the dyad hypothesis. | 3.99e-06 | 2 | 70 | 2 | 23648184 | |
| Pubmed | Expression and function of formyl peptide receptors on human fibroblast cells. | 3.99e-06 | 2 | 70 | 2 | 12902510 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32367481 | ||
| Pubmed | Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II. | 3.99e-06 | 2 | 70 | 2 | 7961887 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22005393 | ||
| Pubmed | Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. | 3.99e-06 | 2 | 70 | 2 | 15123599 | |
| Pubmed | Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status. | 3.99e-06 | 2 | 70 | 2 | 32126143 | |
| Pubmed | Distinct roles for TET family proteins in regulating human erythropoiesis. | 3.99e-06 | 2 | 70 | 2 | 28167661 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28303030 | ||
| Pubmed | Synaptotagmin I and II are present in distinct subsets of central synapses. | 3.99e-06 | 2 | 70 | 2 | 17492637 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8034133 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 1373134 | ||
| Pubmed | Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing. | 3.99e-06 | 2 | 70 | 2 | 24603667 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15625007 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27729528 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23562731 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17234990 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28363983 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23139859 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24956481 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 4.29e-06 | 16 | 70 | 3 | 12904471 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 1.08e-05 | 697 | 70 | 9 | 28298427 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 30074219 | ||
| Pubmed | Mass spectrometric based mapping of the disulfide bonding patterns of integrin alpha chains. | 1.20e-05 | 3 | 70 | 2 | 14596610 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 26733684 | ||
| Pubmed | Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. | 1.20e-05 | 3 | 70 | 2 | 24194590 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19923888 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 22721769 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24011356 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 35382852 | ||
| Pubmed | Selective targeting of TET catalytic domain promotes somatic cell reprogramming. | 1.20e-05 | 3 | 70 | 2 | 32024762 | |
| Pubmed | Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs. | 1.20e-05 | 3 | 70 | 2 | 27184841 | |
| Pubmed | Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors. | 1.20e-05 | 3 | 70 | 2 | 26966188 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19234194 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 21130701 | ||
| Pubmed | Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations. | 1.20e-05 | 3 | 70 | 2 | 23996483 | |
| Pubmed | Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. | 1.20e-05 | 3 | 70 | 2 | 21778364 | |
| Pubmed | Tet family proteins and 5-hydroxymethylcytosine in development and disease. | 1.20e-05 | 3 | 70 | 2 | 22569552 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 12218158 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 11316806 | ||
| Pubmed | Postnatal DNA demethylation and its role in tissue maturation. | 1.20e-05 | 3 | 70 | 2 | 29795194 | |
| Pubmed | S100A4 protects gastric cancer cells from anoikis through regulation of αv and α5 integrin. | 1.20e-05 | 3 | 70 | 2 | 21352421 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 26980223 | ||
| Pubmed | Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. | 1.20e-05 | 3 | 70 | 2 | 12459252 | |
| Pubmed | Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst. | 1.20e-05 | 3 | 70 | 2 | 32403233 | |
| Pubmed | Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. | 1.20e-05 | 3 | 70 | 2 | 19372391 | |
| Pubmed | Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin. | 1.20e-05 | 3 | 70 | 2 | 27599164 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 30987683 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 8599839 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24478423 | ||
| Pubmed | Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. | 1.20e-05 | 3 | 70 | 2 | 29048538 | |
| Pubmed | Inflammation-induced interstitial migration of effector CD4⁺ T cells is dependent on integrin αV. | 1.20e-05 | 3 | 70 | 2 | 23933892 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 17446174 | ||
| Pubmed | Functional expression of formyl peptide receptor family in human NK cells. | 1.20e-05 | 3 | 70 | 2 | 19843937 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 31116781 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 25608811 | ||
| Pubmed | Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. | 1.20e-05 | 3 | 70 | 2 | 19420352 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 28218476 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23548903 | ||
| Pubmed | Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. | 1.20e-05 | 3 | 70 | 2 | 19625660 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19498085 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 31398292 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 16410239 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23164356 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34919053 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 15051489 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24958354 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23643243 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 20151413 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23454745 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 14709554 | ||
| Pubmed | Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. | 1.20e-05 | 3 | 70 | 2 | 28473400 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 11035110 | ||
| Pubmed | Tissue-specific DNA demethylation is required for proper B-cell differentiation and function. | 1.20e-05 | 3 | 70 | 2 | 27091986 | |
| Pubmed | Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation. | 1.20e-05 | 3 | 70 | 2 | 34879277 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 10871287 | ||
| Pubmed | Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties. | 1.20e-05 | 3 | 70 | 2 | 22859307 | |
| Pubmed | [Expression and significance of integrins subunits in laryngeal squamous cell carcinoma]. | 1.20e-05 | 3 | 70 | 2 | 20942236 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 33789297 | ||
| Interaction | C3orf52 interactions | ABCC4 SLC10A2 SLC12A9 TMEM94 PVR SREBF1 CYP4F22 ATP2A3 CDKAL1 | 4.91e-07 | 305 | 64 | 9 | int:C3orf52 |
| Interaction | KDELR3 interactions | 5.78e-07 | 51 | 64 | 5 | int:KDELR3 | |
| Interaction | EXOG interactions | 6.38e-07 | 52 | 64 | 5 | int:EXOG | |
| Interaction | TMEM268 interactions | 1.54e-06 | 27 | 64 | 4 | int:TMEM268 | |
| Interaction | TTYH1 interactions | 4.72e-06 | 300 | 64 | 8 | int:TTYH1 | |
| Interaction | CERS5 interactions | 5.05e-06 | 36 | 64 | 4 | int:CERS5 | |
| Interaction | XPO6 interactions | 8.81e-06 | 88 | 64 | 5 | int:XPO6 | |
| Interaction | MSMO1 interactions | 9.84e-06 | 90 | 64 | 5 | int:MSMO1 | |
| Interaction | IPO11 interactions | 1.13e-05 | 159 | 64 | 6 | int:IPO11 | |
| Interaction | PIGH interactions | 1.21e-05 | 161 | 64 | 6 | int:PIGH | |
| Interaction | CD160 interactions | 1.62e-05 | 48 | 64 | 4 | int:CD160 | |
| Interaction | SLC30A2 interactions | 1.81e-05 | 102 | 64 | 5 | int:SLC30A2 | |
| Interaction | ATL2 interactions | 1.99e-05 | 104 | 64 | 5 | int:ATL2 | |
| Interaction | NOMO1 interactions | 2.35e-05 | 181 | 64 | 6 | int:NOMO1 | |
| Interaction | ENTPD4 interactions | 2.85e-05 | 19 | 64 | 3 | int:ENTPD4 | |
| Interaction | TMCO1 interactions | 3.28e-05 | 192 | 64 | 6 | int:TMCO1 | |
| Interaction | ATP2B2 interactions | 3.89e-05 | 198 | 64 | 6 | int:ATP2B2 | |
| Interaction | ABCB8 interactions | 3.95e-05 | 60 | 64 | 4 | int:ABCB8 | |
| Interaction | GPR89A interactions | 3.96e-05 | 120 | 64 | 5 | int:GPR89A | |
| Interaction | PIGO interactions | 5.41e-05 | 65 | 64 | 4 | int:PIGO | |
| Interaction | TMEM161A interactions | 7.25e-05 | 70 | 64 | 4 | int:TMEM161A | |
| Interaction | LCN9 interactions | 8.46e-05 | 27 | 64 | 3 | int:LCN9 | |
| Interaction | ATP2A3 interactions | 9.37e-05 | 232 | 64 | 6 | int:ATP2A3 | |
| Interaction | TMEM161B interactions | 9.45e-05 | 28 | 64 | 3 | int:TMEM161B | |
| Interaction | AUP1 interactions | 9.82e-05 | 234 | 64 | 6 | int:AUP1 | |
| Interaction | OR4N2 interactions | 1.05e-04 | 29 | 64 | 3 | int:OR4N2 | |
| Interaction | DPH6 interactions | 1.29e-04 | 31 | 64 | 3 | int:DPH6 | |
| Interaction | OXA1L interactions | 1.29e-04 | 154 | 64 | 5 | int:OXA1L | |
| Interaction | ZW10 interactions | 1.33e-04 | 155 | 64 | 5 | int:ZW10 | |
| Interaction | HACD2 interactions | 1.34e-04 | 82 | 64 | 4 | int:HACD2 | |
| Interaction | GNPAT interactions | 1.41e-04 | 83 | 64 | 4 | int:GNPAT | |
| Interaction | SYP interactions | 1.46e-04 | 158 | 64 | 5 | int:SYP | |
| Interaction | AP5Z1 interactions | 1.56e-04 | 33 | 64 | 3 | int:AP5Z1 | |
| Interaction | CPT1A interactions | 1.64e-04 | 162 | 64 | 5 | int:CPT1A | |
| Interaction | RXFP1 interactions | 1.93e-04 | 90 | 64 | 4 | int:RXFP1 | |
| Interaction | PEX3 interactions | 2.11e-04 | 171 | 64 | 5 | int:PEX3 | |
| Interaction | INSRR interactions | 2.18e-04 | 93 | 64 | 4 | int:INSRR | |
| Interaction | ABHD12 interactions | 2.37e-04 | 95 | 64 | 4 | int:ABHD12 | |
| Interaction | CIP2A interactions | 2.41e-04 | 176 | 64 | 5 | int:CIP2A | |
| Interaction | XPO7 interactions | 2.48e-04 | 177 | 64 | 5 | int:XPO7 | |
| Interaction | MS4A15 interactions | 2.57e-04 | 39 | 64 | 3 | int:MS4A15 | |
| Interaction | ATL3 interactions | 2.61e-04 | 179 | 64 | 5 | int:ATL3 | |
| Interaction | NCLN interactions | 2.89e-04 | 183 | 64 | 5 | int:NCLN | |
| Interaction | DGAT1 interactions | 2.99e-04 | 41 | 64 | 3 | int:DGAT1 | |
| Interaction | TTI1 interactions | 3.00e-04 | 101 | 64 | 4 | int:TTI1 | |
| Interaction | GPAT3 interactions | 3.11e-04 | 102 | 64 | 4 | int:GPAT3 | |
| Interaction | CERS6 interactions | 3.35e-04 | 104 | 64 | 4 | int:CERS6 | |
| Interaction | FCSK interactions | 3.44e-04 | 43 | 64 | 3 | int:FCSK | |
| Interaction | SIMC1 interactions | 3.69e-04 | 44 | 64 | 3 | int:SIMC1 | |
| Interaction | DOP1B interactions | 3.69e-04 | 44 | 64 | 3 | int:DOP1B | |
| Interaction | ATP2A1 interactions | 3.79e-04 | 423 | 64 | 7 | int:ATP2A1 | |
| Interaction | FAR2 interactions | 3.94e-04 | 45 | 64 | 3 | int:FAR2 | |
| Interaction | SCD5 interactions | 4.21e-04 | 46 | 64 | 3 | int:SCD5 | |
| Interaction | ANGPTL3 interactions | 4.39e-04 | 10 | 64 | 2 | int:ANGPTL3 | |
| Interaction | PIEZO1 interactions | 4.48e-04 | 47 | 64 | 3 | int:PIEZO1 | |
| Interaction | HS2ST1 interactions | 5.24e-04 | 117 | 64 | 4 | int:HS2ST1 | |
| Interaction | CCDC47 interactions | 5.33e-04 | 448 | 64 | 7 | int:CCDC47 | |
| Interaction | FAAH interactions | 5.36e-04 | 11 | 64 | 2 | int:FAAH | |
| Interaction | SUSD4 interactions | 5.38e-04 | 50 | 64 | 3 | int:SUSD4 | |
| Interaction | TSPO interactions | 5.71e-04 | 51 | 64 | 3 | int:TSPO | |
| Interaction | GPR182 interactions | 5.85e-04 | 455 | 64 | 7 | int:GPR182 | |
| Interaction | BPIFB1 interactions | 6.39e-04 | 53 | 64 | 3 | int:BPIFB1 | |
| Interaction | CD226 interactions | 6.39e-04 | 53 | 64 | 3 | int:CD226 | |
| Interaction | C17orf78 interactions | 6.42e-04 | 12 | 64 | 2 | int:C17orf78 | |
| Interaction | OS9 interactions | 6.56e-04 | 219 | 64 | 5 | int:OS9 | |
| Interaction | TMPRSS2 interactions | 6.94e-04 | 337 | 64 | 6 | int:TMPRSS2 | |
| Interaction | TAFA4 interactions | 7.12e-04 | 55 | 64 | 3 | int:TAFA4 | |
| Interaction | LGALS3 interactions | 7.26e-04 | 340 | 64 | 6 | int:LGALS3 | |
| Interaction | TVP23C interactions | 7.51e-04 | 56 | 64 | 3 | int:TVP23C | |
| Interaction | GPAT4 interactions | 7.56e-04 | 129 | 64 | 4 | int:GPAT4 | |
| Interaction | YIF1A interactions | 7.56e-04 | 129 | 64 | 4 | int:YIF1A | |
| Interaction | XPO5 interactions | 7.71e-04 | 227 | 64 | 5 | int:XPO5 | |
| Interaction | SPG11 interactions | 7.91e-04 | 57 | 64 | 3 | int:SPG11 | |
| Interaction | GCN1 interactions | 8.32e-04 | 349 | 64 | 6 | int:GCN1 | |
| Interaction | GML interactions | 8.32e-04 | 58 | 64 | 3 | int:GML | |
| Interaction | EIF2B4 interactions | 8.72e-04 | 134 | 64 | 4 | int:EIF2B4 | |
| Interaction | TMEM25 interactions | 8.72e-04 | 134 | 64 | 4 | int:TMEM25 | |
| Interaction | TTI2 interactions | 8.75e-04 | 59 | 64 | 3 | int:TTI2 | |
| Interaction | HLA-C interactions | 8.83e-04 | 353 | 64 | 6 | int:HLA-C | |
| Interaction | TELO2 interactions | 8.96e-04 | 135 | 64 | 4 | int:TELO2 | |
| Interaction | URB1 interactions | 8.96e-04 | 135 | 64 | 4 | int:URB1 | |
| Interaction | CTXN3 interactions | 9.19e-04 | 60 | 64 | 3 | int:CTXN3 | |
| Interaction | ARFGEF2 interactions | 9.21e-04 | 136 | 64 | 4 | int:ARFGEF2 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.58e-05 | 18 | 50 | 3 | 1160 | |
| GeneFamily | Formyl peptide receptors | 2.24e-05 | 3 | 50 | 2 | 198 | |
| GeneFamily | ATPases Ca2+ transporting | 2.67e-04 | 9 | 50 | 2 | 1209 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.29e-04 | 394 | 50 | 6 | 471 | |
| GeneFamily | Synaptotagmins | 9.93e-04 | 17 | 50 | 2 | 765 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.24e-03 | 19 | 50 | 2 | 50 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 1.52e-03 | 21 | 50 | 2 | 680 | |
| GeneFamily | Cytochrome P450 family 4 | 4.45e-03 | 36 | 50 | 2 | 1003 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.97e-02 | 78 | 50 | 2 | 262 | |
| GeneFamily | Solute carriers | 2.35e-02 | 395 | 50 | 4 | 752 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 5.66e-07 | 191 | 70 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.19e-07 | 199 | 70 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.36e-06 | 160 | 70 | 5 | 08696d93ff42a1beca23c70ab3e0d082cfff4aa7 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 161 | 70 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 161 | 70 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 164 | 70 | 5 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 171 | 70 | 5 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 171 | 70 | 5 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-06 | 173 | 70 | 5 | 0a0127bcb1d7b2b6125faef576dd843055095528 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 173 | 70 | 5 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 185 | 70 | 5 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 190 | 70 | 5 | b8c131020d20005cd9f23d26312196f62c958074 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.40e-05 | 195 | 70 | 5 | 7606b8b40e704bb5447ac57ccf8698794e9c7890 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 195 | 70 | 5 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-05 | 196 | 70 | 5 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-05 | 196 | 70 | 5 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-05 | 196 | 70 | 5 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 198 | 70 | 5 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | mild-Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.54e-05 | 199 | 70 | 5 | 2fd5759acf49c02c5bbcc2941676216e7444d76d | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-05 | 199 | 70 | 5 | fdd8c4c04837341e17a4772a2adcdf2f187c56b1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | f0e7c2f07a7065511bf0b6521ce2e74e04e48544 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.45e-05 | 137 | 70 | 4 | 264d5e06c37d1a9ef7748091b67d2a5aa803096e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related-Oligodendrocyte/OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.45e-05 | 137 | 70 | 4 | 8ce463d1d74ac0ce80b812217d6bd76a788f14d2 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.90e-05 | 153 | 70 | 4 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-04 | 155 | 70 | 4 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 70 | 4 | c3451b33780499fd62672e7cd71c7e8cb6ccc2c5 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 70 | 4 | 92cd58b62e46b93f90e05657fd201404ccae6ddb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 70 | 4 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 159 | 70 | 4 | 555ebf719504980c7584203a3ee1ba5779ab76d8 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 159 | 70 | 4 | a6a5cded6da02a112e04c2c71ce08cc27c1c5002 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | b73f07a0088936fbc3656a05710a67f38b4ae551 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.18e-04 | 160 | 70 | 4 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | b88876a58fea2066468e74dcc439c8561130a910 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 161 | 70 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 161 | 70 | 4 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 161 | 70 | 4 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 161 | 70 | 4 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 162 | 70 | 4 | f24eb596653180040bfdefad9c246fc42cbfaac8 | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 162 | 70 | 4 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 162 | 70 | 4 | 1a953e165b7e469815294728350ec13d27c9bd9d | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.26e-04 | 163 | 70 | 4 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | 8d089844896e84935eab705ebe54f125c4b6d9ca | |
| ToppCell | droplet-Fat-Gat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | c7ad946829c655038b33748dddd7d68c15489034 | |
| ToppCell | droplet-Fat-Gat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | 3aae702a23fbf1d36a6f18596c23e985581de815 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 164 | 70 | 4 | 2c929996a19bbe29949010928001c277b5494a42 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | 17fb1421476ba44999b1165f2576514f74c1f882 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 70 | 4 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 165 | 70 | 4 | 354978d4f35154d7b2e36e94de669e045adef512 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 166 | 70 | 4 | 6a65dff1333f39ec8c584e6df04b8c1e7f1c8946 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 167 | 70 | 4 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 167 | 70 | 4 | c7d1e84af1f4d7430858287520ac2cfa36203642 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-04 | 167 | 70 | 4 | 9526e2c7673d569d04e0728a2526318e67432e0a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 167 | 70 | 4 | 4e613be2b3ba01160b0c0254fce3c4f72220e580 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 167 | 70 | 4 | 18ad85751bd892309627eefc357eb28ec5a7c300 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 168 | 70 | 4 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 168 | 70 | 4 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 168 | 70 | 4 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 168 | 70 | 4 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 170 | 70 | 4 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 171 | 70 | 4 | 0417fa805ca0acb7e9f6a30bc7b6bdbaba77844d | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-04 | 171 | 70 | 4 | 459e1ac0b89571c39db98c0f578eca8f46caa8e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 171 | 70 | 4 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 66 | 70 | 3 | 88afd3ab91774ce01ff4277395b7b59dbb23200a | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 172 | 70 | 4 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.55e-04 | 172 | 70 | 4 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | 8e91831804a120037c71cd4e74af686f3c32d31c | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | ea4da9aab7a2ff854df21da01d11c9ed99e41fb4 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.55e-04 | 172 | 70 | 4 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 1.55e-04 | 172 | 70 | 4 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 173 | 70 | 4 | 9eaec30f9a3655b53ece1b66848201a7f85bbdf5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 173 | 70 | 4 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.62e-04 | 174 | 70 | 4 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 1.62e-04 | 174 | 70 | 4 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 1.70e-04 | 176 | 70 | 4 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 177 | 70 | 4 | 23c1bce4ae3b94f56263f5a9f6bbd1805c097a12 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.73e-04 | 177 | 70 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 177 | 70 | 4 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.73e-04 | 177 | 70 | 4 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 177 | 70 | 4 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 178 | 70 | 4 | 4ef6344d0ffc9c55b1240bee94b741382f1427bb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 178 | 70 | 4 | c65932cbedbbfacb6f0299280663fe7c88dba72b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| Computational | Neighborhood of TNFSF10 | 1.55e-04 | 30 | 38 | 3 | GNF2_TNFSF10 | |
| Computational | Genes in the cancer module 301. | 2.18e-04 | 158 | 38 | 5 | MODULE_301 | |
| Computational | Genes in the cancer module 238. | 2.60e-04 | 164 | 38 | 5 | MODULE_238 | |
| Computational | Genes in the cancer module 146. | 4.40e-04 | 102 | 38 | 4 | MODULE_146 | |
| Computational | Genes in the cancer module 145. | 6.07e-04 | 111 | 38 | 4 | MODULE_145 | |
| Computational | Genes in the cancer module 412. | 9.26e-04 | 13 | 38 | 2 | MODULE_412 | |
| Computational | Genes in the cancer module 436. | 1.37e-03 | 138 | 38 | 4 | MODULE_436 | |
| Computational | Genes in the cancer module 188. | 1.41e-03 | 139 | 38 | 4 | MODULE_188 | |
| Computational | Genes in the cancer module 275. | 1.42e-03 | 16 | 38 | 2 | MODULE_275 | |
| Computational | B lymphoma expression clusters. | 1.81e-03 | 149 | 38 | 4 | MODULE_361 | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.24e-06 | 197 | 69 | 7 | 2636_DN | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 3.13e-05 | 4 | 68 | 2 | DOID:0110659 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 4.33e-05 | 84 | 68 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 5.21e-05 | 5 | 68 | 2 | DOID:439 (implicated_via_orthology) | |
| Disease | Hyperphosphatasia-intellectual disability syndrome | 7.80e-05 | 6 | 68 | 2 | cv:C1855923 | |
| Disease | Hyperphosphatasia with Mental Retardation | 1.09e-04 | 7 | 68 | 2 | C1855923 | |
| Disease | melanoma | 2.09e-04 | 126 | 68 | 4 | EFO_0000756 | |
| Disease | Complications of Diabetes Mellitus | 2.84e-04 | 11 | 68 | 2 | C0342257 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 3.40e-04 | 12 | 68 | 2 | EFO_0008284 | |
| Disease | hemorrhoid | 3.76e-04 | 147 | 68 | 4 | EFO_0009552 | |
| Disease | Intellectual Disability | 5.79e-04 | 447 | 68 | 6 | C3714756 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 6.15e-04 | 16 | 68 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 6.75e-04 | 74 | 68 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 6.94e-04 | 173 | 68 | 4 | C0023467 | |
| Disease | intellectual disability (implicated_via_orthology) | 7.02e-04 | 75 | 68 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 7.82e-04 | 18 | 68 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | myeloid white cell count | 1.38e-03 | 937 | 68 | 8 | EFO_0007988 | |
| Disease | Anaplastic astrocytoma | 1.77e-03 | 27 | 68 | 2 | C0334579 | |
| Disease | glucose measurement | 1.85e-03 | 380 | 68 | 5 | EFO_0004468 | |
| Disease | hypertension (biomarker_via_orthology) | 1.89e-03 | 227 | 68 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | chloride measurement | 2.04e-03 | 29 | 68 | 2 | EFO_0009284 | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 2.18e-03 | 30 | 68 | 2 | DOID:0050908 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWVLPIVSPLIPIFL | 521 | Q9N2K0 | |
| WFVPLLGPATVILLL | 456 | B6SEH9 | |
| WAAVVVLLGPQLVLL | 6 | Q5T7M4 | |
| LGLPEALIPVQLLWV | 781 | O14983 | |
| LGLPEALIPVQLLWV | 781 | Q93084 | |
| VLPVLLLLVWGLDPG | 11 | Q8TE56 | |
| LPAVLLVIPNAWGRL | 156 | Q6UXT9 | |
| IIAVVLGVIWGVLPL | 51 | Q9BUV8 | |
| PSPGILIISWLPVTI | 991 | O95153 | |
| LLAWLGIPNVLLEVV | 206 | Q6IWH7 | |
| LLKPILWAEPGPVIT | 26 | P59901 | |
| VWLVAPLIARLPTSV | 1411 | Q86YW9 | |
| LWTILPPKLAQEILV | 646 | Q8IV33 | |
| IVGPWILALVLTLPV | 146 | P25090 | |
| AVIVPLLLLIGLALW | 306 | P06126 | |
| LIPLLVWITTLPKID | 446 | Q9BUQ8 | |
| ELWPVLLGFTILPAI | 206 | Q8TDB8 | |
| EVQTPKWITPVLLLI | 1576 | Q7Z6Z7 | |
| LLGGVVIVLLRWPLL | 71 | Q6ZVE7 | |
| PLWVIILAILLGLLV | 1011 | P53708 | |
| VAVAVIPWIAIPLVP | 856 | O15439 | |
| IPWIAIPLVPLGIIF | 861 | O15439 | |
| WPLTILVLSVIPVVA | 351 | Q9UHC9 | |
| GVPLWIIILAILFGL | 996 | P08648 | |
| QPCLLLPIVPLSWLV | 21 | O75173 | |
| NIPRLVSGWVKPIII | 116 | O75874 | |
| IWVGALLLALPEVVL | 386 | O15354 | |
| LPTLLWKLVEVIPEG | 271 | Q5VV42 | |
| LWPVEITRVPLVTIP | 306 | Q5T0N1 | |
| LGPVAASPWLLLLLV | 11 | Q9HBI6 | |
| PVPVWVIILAVLAGL | 991 | P06756 | |
| SLEVEWTLVLLAIPP | 51 | J3KSC0 | |
| WPLIRFLVPLGITNI | 11 | Q9HCJ1 | |
| VELVARILALVPPWT | 346 | Q9H9T3 | |
| MWTLVPPLLLLGLVV | 91 | A6NNB3 | |
| PVLAVVATFPVLILW | 471 | Q9H4A9 | |
| LIPVSIWVAVLLGGL | 481 | O00219 | |
| PLIWSFAGPVVLVIV | 2681 | Q9NYQ7 | |
| LVPLLGIEFVLIPWR | 341 | Q16602 | |
| LLVWMGPVLPLLVLV | 96 | Q6NT55 | |
| IIAPKLWIIGTIFPV | 221 | Q12908 | |
| LLVPLVLEPGLWSLV | 196 | Q96C03 | |
| LLLVALLVLSWPPPG | 11 | P15151 | |
| WVKLPPVIPAQIVIA | 441 | Q5TD94 | |
| LPPWALIAIAIVAVL | 56 | P21579 | |
| PPWALIAIAVVAGLL | 61 | Q8N9I0 | |
| LTGPWIKRLLPVIFL | 191 | Q6P4A7 | |
| PLCVTVWVPRLPLQI | 516 | Q8N3T6 | |
| IIGPWVMALLLTLPV | 146 | P21462 | |
| GIWVLSAIIPLPEVV | 176 | O15218 | |
| LLVPTALPLLRVWAV | 46 | Q03518 | |
| VWPLVFLGIGRLAII | 206 | Q7Z7B1 | |
| ITPLLDVGVLPRWVP | 426 | Q96N87 | |
| CVLLSLLPVLWVPVA | 571 | Q96N87 | |
| PPVVWLLNGLLVLVS | 546 | P36956 | |
| QIWATVKPVLVLLPV | 851 | Q7Z7M1 | |
| VKPVLVLLPVLGLTW | 856 | Q7Z7M1 | |
| VLLPVLGLTWLAGIL | 861 | Q7Z7M1 | |
| PPWRLIAVILGILCL | 41 | Q9BXN2 | |
| LLVNPIWLVPPTKAL | 286 | Q96S66 | |
| LALIQVPVWLVLQGP | 81 | Q6UE05 | |
| VDWPPLVLGLLTLLK | 1071 | Q12768 | |
| GVLPILPLLFPVLWV | 321 | Q12767 | |
| WLEVPPIALRDVSII | 926 | Q7Z6L1 | |
| FRAISLWPPLVLIGI | 336 | Q9BXP2 | |
| WPFLGILAEIIILVV | 341 | Q9Y639 | |
| LPPLLVVLLGCWASV | 6 | Q2MV58 | |
| VWPLQIILLILCPEI | 266 | P21359 | |
| IVILILAWEGIPRSL | 921 | O43151 | |
| IWVLVTLELLPILPL | 146 | Q9BXA5 | |
| PVKTFWILIQPSIVI | 21 | Q8TBK6 | |
| PLLLTPVAWGLVGAI | 481 | Q8TEQ8 | |
| LLELVVQAVPLPWLV | 361 | Q00G26 | |
| IPLIWGAVLLVGLLV | 161 | Q86YW5 | |
| IVILILVWEGIPLSL | 1226 | Q6N021 |